Go Pro

This company has been marked as potentially delisted and may not be actively trading.

Esperion Therapeutics (ESPR) Institutional Ownership

Esperion Therapeutics logo

Institutional Ownership Changes (13F Filings) for Esperion Therapeutics (NASDAQ:ESPR)

Current
Institutional Ownership
Percentage
47.39%
Number of
Institutional Buyers
(last 12 months)
124
Total
Institutional Inflows
(last 12 months)
$376.50M
Number of
Institutional Sellers
(last 12 months)
35
Total
Institutional Outflows
(last 12 months)
$106.11M
Get ESPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Esperion Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ESPR Institutional Buying and Selling by Quarter

Esperion Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/21/2026 AXQ Capital LP49,712$157K0.0%-47.2%0.019%
8/20/2026 GTS Securities LLC271,769$859K0.0%N/A0.105%
8/20/2026 Harvest Management LLC200,000$632K0.2%N/A0.078%
8/19/2026 Hsbc Holdings PLC42,710$135K0.0%-11.3%0.017%
8/18/2026 Mint Tower Capital Management B.V.503,300$1.59M0.2%N/A0.195%
8/18/2026 Glazer Capital LLC22,416,339$70.84M1.7%N/A8.699%
8/18/2026 PSquared Asset Management AG3,300,000$10.43M3.4%N/A1.281%
8/18/2026 Equitable Holdings Inc.23,000$73K0.0%N/A0.009%
8/18/2026 PenderFund Capital Management Ltd.3,884,508$12.28M1.6%N/A1.507%
8/17/2026 One68 Global Capital LLC30,000$95K0.2%N/A0.012%
8/17/2026 Corient Private Wealth LP11,802$37K0.0%N/A0.005%
8/17/2026 Bank of America Corp DE450,625$1.42M0.0%N/A0.175%
8/15/2026 Polar Asset Management Partners Inc.1,508,892$4.77M0.1%N/A0.586%
8/15/2026 Kintayl Capital LP400,000$1.26M0.5%N/A0.155%
8/14/2026 Hsbc Holdings PLC42,710$135K0.0%N/A0.017%
8/14/2026 Canada Pension Plan Investment Board30,900$98K0.0%N/A0.012%
8/14/2026 Legal & General Group Plc24,561$78K0.0%N/A0.010%
8/14/2026 The Manufacturers Life Insurance Company 66,577$210K0.0%N/A0.026%
8/10/2026 Bantamac Capital LLC13,000$41K0.0%N/A0.005%
8/7/2026 BlackRock Inc.22,128,021$69.93M0.0%N/A8.587%
8/7/2026 Deutsche Bank AG266,396$842K0.0%N/A0.103%
8/6/2026 Bank of New York Mellon Corp732,616$2.32M0.0%N/A0.284%
8/6/2026 Stoneridge Investment Partners LLC18,237$58K0.0%N/A0.007%
8/3/2026 PSI Advisors LLC11,172$35K0.0%N/A0.004%
7/10/2026 Wasatch Advisors LP1,930,185$6.10M0.0%-87.8%0.749%
7/8/2026 FNY Investment Advisers LLC110,000$347K0.1%N/A0.043%
6/3/2026 Parallel Advisors LLC96,254$264K0.0%-9.8%0.037%
5/19/2026 Bank of America Corp DE249,395$683K0.0%-64.2%0.097%
5/18/2026 ADAR1 Capital Management LLC21,400$59K0.0%N/A0.008%
5/18/2026 Eversept Partners LP1,735,963$4.76M0.3%-54.9%0.674%
5/16/2026 The Manufacturers Life Insurance Company64,523$177K0.0%-7.9%0.025%
5/16/2026 Excelsior Advisor Network LLC45,000$123K0.0%N/A0.017%
5/16/2026 Lazard Asset Management LLC580,705$1.59M0.0%+1,621.1%0.226%
5/16/2026 Orbimed Advisors LLC10,570,300$28.96M0.5%+77.2%4.106%
5/14/2026 Renaissance Technologies LLC1,620,100$4.44M0.0%-26.2%0.629%
5/14/2026 Public Employees Retirement System of Ohio521,081$1.43M0.0%N/A0.202%
5/14/2026 Sei Investments Co.116,229$318K0.0%+52.9%0.045%
5/14/2026 Lido Advisors LLC99,139$272K0.0%N/A0.039%
5/14/2026 State of Wyoming105,182$288K0.0%+66.0%0.041%
5/7/2026 Parallel Advisors LLC96,254$264K0.0%-9.8%0.037%
They didn't warn anyone in 1971. This time someone is warning you. (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
5/5/2026 Bank of New York Mellon Corp555,177$1.52M0.0%+1.1%0.216%
5/4/2026 Summit Wealth Group LLC405,369$1.11M0.3%+19.0%0.157%
5/4/2026 Principal Financial Group Inc.422,776$1.16M0.0%+53.0%0.164%
4/30/2026 Hsbc Holdings PLC48,141$132K0.0%+160.1%0.019%
4/30/2026 AIGH Capital Management LLC4,400,000$12.06M1.6%+10.0%1.709%
4/28/2026 Abel Hall LLC12,496$34K0.0%-56.8%0.005%
4/21/2026 Wasatch Advisors LP15,768,897$43.21M0.3%+66.9%6.126%
4/16/2026 SG Americas Securities LLC127,983$351K0.0%+151.0%0.050%
3/20/2026 Hsbc Holdings PLC18,510$70K0.0%N/A0.007%
3/3/2026 Caitong International Asset Management Co. Ltd36,744$136K0.0%+17.6%0.015%
2/19/2026 Invesco Ltd.765,118$2.83M0.0%+23.5%0.320%
2/18/2026 Mackenzie Financial Corp336,992$1.24M0.0%+23.5%0.141%
2/18/2026 XTX Topco Ltd161,974$599K0.0%N/A0.068%
2/18/2026 nVerses Capital LLC67,450$250K0.6%N/A0.028%
2/18/2026 Virtus Investment Advisers LLC177,508$657K0.2%N/A0.074%
2/18/2026 Wellington Management Group LLP641,178$2.37M0.0%-5.9%0.268%
2/18/2026 Quadrature Capital Ltd259,563$960K0.0%N/A0.109%
2/18/2026 Orbimed Advisors LLC5,965,498$22.07M0.5%N/A2.495%
2/18/2026 Millennium Management LLC3,932,274$14.55M0.0%+303.4%1.645%
2/18/2026 Eversept Partners LP3,851,133$14.25M0.7%N/A1.611%
2/18/2026 ACT Capital Management LLC47,500$176K0.1%N/A0.020%
2/17/2026 Schonfeld Strategic Advisors LLC75,238$278K0.0%N/A0.031%
2/17/2026 Burkehill Global Management LP400,000$1.48M0.1%N/A0.167%
2/17/2026 AQR Capital Management LLC290,514$1.08M0.0%+2.0%0.122%
2/17/2026 Abel Hall LLC28,943$107K0.0%+138.4%0.012%
2/17/2026 Cetera Investment Advisers31,803$118K0.0%-47.7%0.013%
2/17/2026 Lazard Asset Management LLC33,741$125K0.0%N/A0.014%
2/17/2026 PenderFund Capital Management Ltd.4,391,926$16.25M2.6%-54.6%1.837%
2/17/2026 Price T Rowe Associates Inc. MD188,639$698K0.0%+23.4%0.079%
2/17/2026 Osaic Holdings Inc.86,443$320K0.0%+6.2%0.036%
2/17/2026 Russell Investments Group Ltd.21,573$80K0.0%-98.7%0.009%
2/17/2026 Captrust Financial Advisors10,858$40K0.0%N/A0.005%
2/17/2026 ExodusPoint Capital Management LP34,815$129K0.0%N/A0.015%
2/17/2026 Royal Bank of Canada8,576$32K0.0%-99.1%0.004%
2/17/2026 Graham Capital Management L.P.161,557$598K0.0%+968.9%0.068%
2/16/2026 Mariner LLC278,661$1.03M0.0%-7.9%0.117%
2/16/2026 Barclays PLC443,339$1.64M0.0%+32.1%0.185%
2/13/2026 Kestra Advisory Services LLC9,570$35K0.0%N/A0.004%
2/13/2026 Marshall Wace LLP5,471,611$20.25M0.0%+117.0%2.289%
2/13/2026 Hudson Bay Capital Management LP18,230$67K0.0%N/A0.008%
2/13/2026 Rafferty Asset Management LLC61,045$226K0.0%+116.1%0.026%
2/13/2026 Headlands Technologies LLC221,088$818K0.1%+129.7%0.092%
2/13/2026 Velan Capital Investment Management LP1,210,000$4.48M2.6%N/A0.506%
2/13/2026 Charles Schwab Investment Management Inc.715,326$2.65M0.0%+22.0%0.299%
2/13/2026 State Street Corp5,930,296$21.94M0.0%+32.4%2.481%
2/13/2026 Wells Fargo & Company MN263,188$974K0.0%+80.4%0.110%
2/13/2026 Summit Financial LLC107,263$397K0.0%+8.7%0.045%
2/12/2026 Wasatch Advisors LP9,445,759$34.95M0.2%+33.8%3.951%
2/12/2026 HRT Financial LP239,360$885K0.0%+51.6%0.100%
2/12/2026 MetLife Investment Management LLC129,735$480K0.0%+21.8%0.054%
My top 3 AI picks for the next decade (Ad)

Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.tc pixel

Click here to get all three AI stock names from Alexander Green
2/12/2026Cibc World Markets Corp15,477$57K0.0%N/A0.006%
2/12/2026 Commonwealth Equity Services LLC23,009$85K0.0%+31.4%0.010%
2/12/2026 Tocqueville Asset Management L.P.107,000$396K0.0%+17.6%0.045%
2/12/2026 Renaissance Technologies LLC2,194,600$8.12M0.0%+183.6%0.918%
2/12/2026 EntryPoint Capital LLC23,500$87K0.0%N/A0.010%
2/12/2026 Integrated Quantitative Investments LLC72,249$267K0.1%N/A0.030%
2/12/2026 New York State Common Retirement Fund63,900$236K0.0%+103.5%0.027%
2/12/2026 Bank of Montreal Can51,923$192K0.0%+24.0%0.022%
2/12/2026 Polen Capital Management LLC116,292$430K0.0%N/A0.049%
2/12/2026 Nuveen LLC3,612,113$13.37M0.0%-2.7%1.511%


ESPR Institutional Ownership - Frequently Asked Questions

During the previous two years, 175 institutional investors and hedge funds held shares of Esperion Therapeutics. The most heavily invested institutionals were Glazer Capital LLC ($70.84M), BlackRock Inc. ($69.93M), Vanguard Group Inc. ($55.30M), Two Seas Capital LP ($44.04M), Orbimed Advisors LLC ($28.96M), State Street Corp ($21.94M), and Geode Capital Management LLC ($21.23M).Learn more on Esperion Therapeutics' institutional investors.

47.39% of Esperion Therapeutics' stock is owned by institutional investors. Learn more on ESPR's institutional investor holdings.

Of the 154 institutional investors that purchased Esperion Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Glazer Capital LLC ($22.42M), BlackRock Inc. ($22.13M), Wasatch Advisors LP ($16.33M), Orbimed Advisors LLC ($10.57M), Two Seas Capital LP ($5.18M), Marshall Wace LLP ($4.63M), and AIGH Capital Management LLC ($4.40M).

Institutional investors have bought a total of 116,653,821 shares in the last 24 months. This purchase volume represents approximately $376.50M in transactions.

Of the 35 institutional investors that sold Esperion Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wasatch Advisors LP ($17.12M), PenderFund Capital Management Ltd. ($5.28M), Marshall Wace LLP ($2.79M), Eversept Partners LP ($2.12M), Russell Investments Group Ltd. ($1.69M), Woodline Partners LP ($1.12M), and Bank of America Corp DE ($979.16K).

Institutional investors have sold a total of 34,038,478 shares in the last 24 months. This volume of shares sold represents approximately $106.11M in transactions.



Institutional ownership data for NASDAQ:ESPR is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/21/2026. New 13F filings are added each quarter as they're published.
From Our Partners